Canopy Growth (CGC) Other Working Capital Changes (2019 - 2025)
Canopy Growth (CGC) reported Other Working Capital Changes of $2.3 million for Q4 2025, up 163.24% on a YoY basis from $860251.2 in Q4 2024, and up 17.61% sequentially from $1.9 million in Q2 2025.
Canopy Growth (CGC) Other Working Capital Changes (2019 - 2025) Analysis & Trends
Canopy Growth (CGC) has 7 years of Other Working Capital Changes data on file, last reported at $2.3 million in Q4 2025.
- For the quarter ending Q4 2025, Other Working Capital Changes rose 163.24% year-over-year to $2.3 million; the trailing twelve-month figure through Dec 2025 stood at $4.6 million (up 165.65% YoY), and the FY2026 full-year result was $3.2 million, up 179.9% from the prior year.
- Other Working Capital Changes rose to $2.3 million in Q4 2025, from $1.9 million in the prior quarter.
- In the past five years, Other Working Capital Changes ranged from a high of $9.0 million in Q4 2021 to a low of -$38.9 million in Q3 2021.
- A 5-year average of -$1.5 million and a median of $727078.2 in 2023 frame the typical range for Other Working Capital Changes.
- Across the five-year window, Other Working Capital Changes sank 1263.15% in 2023 and jumped 1323.57% in 2025, its largest moves.
- Tracing CGC's Other Working Capital Changes over 5 years: stood at $9.0 million in 2021, then slumped by 170.07% to -$6.3 million in 2022, then surged by 106.88% to $435579.6 in 2023, then slumped by 922.05% to -$3.6 million in 2024, then jumped by 163.24% to $2.3 million in 2025.
- Business Quant data shows CGC's Other Working Capital Changes at $2.3 million in Q4 2025, $1.9 million in Q2 2025, and -$3.6 million in Q4 2024.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn |
| 10 | Canopy Growth | 197.77 Mn | -68.15 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 2.26 Mn |
| Dec 31, 2025 | 2.26 Mn |
| Dec 31, 2025 | 2.26 Mn |
| Jun 30, 2025 | 1.93 Mn |
| Jun 30, 2025 | 1.93 Mn |
| Jun 30, 2025 | 1.93 Mn |
| Dec 31, 2024 | -3.58 Mn |
| Dec 31, 2024 | -3.58 Mn |
| Dec 31, 2024 | -3.58 Mn |
| Sep 30, 2024 | 4.00 Mn |
| Sep 30, 2024 | 4.00 Mn |
| Sep 30, 2024 | 4.00 Mn |
| Jun 30, 2024 | 135,261.00 |
| Jun 30, 2024 | 135,261.00 |
| Jun 30, 2024 | 135,261.00 |
| Mar 31, 2024 | 1.18 Mn |
| Mar 31, 2024 | 1.18 Mn |
| Mar 31, 2024 | 1.18 Mn |
| Dec 31, 2023 | 435,579.57 |
| Dec 31, 2023 | 435,579.57 |